Loading clinical trials...
Loading clinical trials...
Outcome of Patients with Severe Functional Tricuspid Regurgitation
Conditions
Interventions
Surgery or Transcatheter tricuspid valve intervention
Locations
44
United States
Mayo Clinic Rochester
Rochester, Minnesota, United States
Mount Sinai
New York, New York, United States
Columbia University Medical Center
New York, New York, United States
Montefiore Health System
New York, New York, United States
Vienna Medical University
Vienna, Austria
University of Ottawa Heart Institute
Ottawa, Ontario, Canada
Start Date
September 1, 2022
Primary Completion Date
December 1, 2025
Completion Date
December 1, 2026
Last Updated
March 28, 2025
NCT07433504
NCT07085650
NCT06137807
NCT06922526
NCT04755842
NCT04653428
Lead Sponsor
Ottawa Heart Institute Research Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions